C4 Therapeutics Inc Financial Flexibility Index
C4 Therapeutics Inc financial flexibility index. C4 Therapeutics Inc (CCCC) has a Financial Flexibility Index of -0.01x as of June 2026. Free cash flow of $-1.54 Million (operating CF $-1.57 Million minus capex $37.00K) represents 0% of total liabilities ($112.14 Million). See C4 Therapeutics Inc (CCCC) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of C4 Therapeutics Inc (2018–2025)
Financial flexibility index of C4 Therapeutics Inc from 2018 to 2025. Historical Financial Flexibility Index trend for C4 Therapeutics Inc across 8 annual periods. Explore CCCC operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
C4 Therapeutics Inc Financial Flexibility Index by Year (2018–2025)
C4 Therapeutics Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for C4 Therapeutics Inc. For the full cash flow conversion analysis, see CCCC cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.96x | $-98.09 Million | $-98.69 Million | $102.49 Million | ▼ -96.8% |
| 2024 | -0.49x | $-64.98 Million | $-65.16 Million | $133.62 Million | ▲ +39.7% |
| 2023 | -0.81x | $-105.13 Million | $-106.84 Million | $130.34 Million | ▼ -13.7% |
| 2022 | -0.71x | $-100.44 Million | $-105.94 Million | $141.61 Million | ▲ +3.0% |
| 2021 | -0.73x | $-85.69 Million | $-86.97 Million | $117.16 Million | ▼ -31.1% |
| 2020 | -0.56x | $-66.60 Million | $-67.25 Million | $119.35 Million | ▼ -325.5% |
| 2019 | 0.25x | $56.96 Million | $55.61 Million | $230.22 Million | ▲ +491.7% |
| 2018 | -0.06x | $-14.29 Million | $-16.98 Million | $226.24 Million | — |